A search for the Standard Model Higgs boson in proton–proton collisions with the ATLAS detector at the LHC is presented. The datasets used correspond to integrated luminosities of approximately 4.8 fb−1 collected at √s=7 TeV in 2011 and 5.8 fb−1 at √s=8 TeV in 2012. Individual searches in the channels H→ZZ(⁎)→4ℓ, H→γγ and H→WW(⁎)→eνμν in the 8 TeV data are combined with previously published results of searches for H→ZZ(⁎), WW(⁎), bb and τ+τ− in the 7 TeV data and results from improved analyses of the H→ZZ(⁎)→4ℓ and H→γγ channels in the 7 TeV data. Clear evidence for the production of a neutral boson with a measured mass of 126.0±0.4(stat)±0.4(sys) GeV is presented. This observation, which has a significance of 5.9 standard deviations, corresponding to a background fluctuation probability of 1.7×10−9, is compatible with the production and decay of the Standard Model Higgs boson
A measurement of the Higgs boson mass is presented based on the combined data samples of the ATLAS and CMS experiments at the CERN LHC in the H → γγ and H → ZZ → 4l decay channels. The results are obtained from a simultaneous fit to the reconstructed invariant mass peaks in the two channels and for the two experiments. The measured masses from the individual channels and the two experiments are found to be consistent among themselves. The combined measured mass of the Higgs boson is m H ¼ 125.09 AE 0.21 ðstatÞ AE 0.11 ðsystÞ GeV. DOI: 10.1103/PhysRevLett.114.191803 PACS numbers: 14.80.Bn, 13.85.Qk The study of the mechanism of electroweak symmetry breaking is one of the principal goals of the CERN LHC program. In the standard model (SM), this symmetry breaking is achieved through the introduction of a complex doublet scalar field, leading to the prediction of the Higgs boson H [1-6], whose mass m H is, however, not predicted by the theory. In 2012, the ATLAS and CMS Collaborations at the LHC announced the discovery of a particle with Higgs-boson-like properties and a mass of about 125 GeV [7][8][9]. The discovery was based primarily on mass peaks observed in the γγ and ZZ → l þ l − l 0þ l 0−(denoted H → ZZ → 4l for simplicity) decay channels, where one or both of the Z bosons can be off shell and where l and l 0 denote an electron or muon. With m H known, all properties of the SM Higgs boson, such as its production cross section and partial decay widths, can be predicted. Increasingly precise measurements [10][11][12][13] have established that all observed properties of the new particle, including its spin, parity, and coupling strengths to SM particles are consistent within the uncertainties with those expected for the SM Higgs boson.The ATLAS and CMS Collaborations have independently measured m H using the samples of proton-proton collision data collected in 2011 and 2012, commonly referred to as LHC Run 1. The analyzed samples correspond to approximately 5 fb −1 of integrated luminosity at ffiffi ffi s p ¼ 7 TeV, and 20 fb −1 at ffiffi ffi s p ¼ 8 TeV, for each experiment. Combined results in the context of the separate experiments, as well as those in the individual channels, are presented in Refs. [12,[14][15][16].This Letter describes a combination of the Run 1 data from the two experiments, leading to improved precision for m H . Besides its intrinsic importance as a fundamental parameter, improved knowledge of m H yields more precise predictions for the other Higgs boson properties. Furthermore, the combined mass measurement provides a first step towards combinations of other quantities, such as the couplings. In the SM, m H is related to the values of the masses of the W boson and top quark through loopinduced effects. Taking into account other measured SM quantities, the comparison of the measurements of the Higgs boson, W boson, and top quark masses can be used to directly test the consistency of the SM [17] and thus to search for evidence of physics beyond the SM.The combination is performed usin...
Autoimmunity and inflammation are controlled in part by regulatory B cells, including a recently identified IL-10-competent CD1dhiCD5+ B cell subset termed B10 cells that represents 1–3% of adult mouse spleen B cells. In this study, pathways that influence B10 cell generation and IL-10 production were identified and compared with previously described regulatory B cells. IL-10-competent B cells were predominantly CD1dhiCD5+ in adult spleen and were the prevalent source of IL-10 but not other cytokines. B10 cell development and/or maturation in vivo required Ag receptor diversity and intact signaling pathways, but not T cells, gut-associated flora, or environmental pathogens. Spleen B10 cell frequencies were significantly expanded in aged mice and mice predisposed to autoimmunity, but were significantly decreased in mouse strains that are susceptible to exogenous autoantigen-induced autoimmunity. LPS, PMA, plus ionomycin stimulation in vitro for 5 h induced B10 cells to express cytoplasmic IL-10. However, prolonged LPS or CD40 stimulation (48 h) induced additional adult spleen CD1dhiCD5+ B cells to express IL-10 following PMA+ionomycin stimulation. Prolonged LPS or CD40 stimulation of newborn spleen and adult blood or lymph node CD1dlo and/or CD5− B cells also induced cytoplasmic IL-10 competence in rare B cells, with CD40 ligation uniformly inducing CD5 expression. IL-10 secretion was induced by LPS signaling through MyD88-dependent pathways, but not following CD40 ligation. LPS stimulation also induced rapid B10 cell clonal expansion when compared with other spleen B cells. Thereby, both adaptive and innate signals regulate B10 cell development, maturation, CD5 expression, and competence for IL-10 production.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.